Overview

Randomized Controlled Trial of Intravenous Magnesium Sulfate Versus Terbutaline for Children in the Management of Acute Exacerbation of Asthma

Status:
COMPLETED

Trial end date:
2024-09-30

Target enrollment:

Participant gender:

Summary

This study aimed to fill this gap by comparing the effectiveness of intravenous magnesium sulfate versus terbutaline in children with acute asthma exacerbations, providing evidence-based guidance for clinicians in emergency settings.

Phase:

PHASE3

Details

Lead Sponsor:

Muhammad Aamir Latif

Collaborator:

Nishtar Medical University